skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: HighWire Press (Free Journals) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Syncytia formation by SARS‐CoV‐2‐infected cells
Material Type:
Article
Add to My Research

Syncytia formation by SARS‐CoV‐2‐infected cells

The EMBO journal, 2020-12, Vol.39 (23), p.e106267-n/a [Peer Reviewed Journal]

2020 The Authors ;2020 The Authors. ;2020 EMBO ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2020106267 ;PMID: 33051876

Full text available

2
Syncytia formation by SARS‐CoV‐2‐infected cells
Material Type:
Article
Add to My Research

Syncytia formation by SARS‐CoV‐2‐infected cells

The EMBO journal, 2021-02, Vol.40 (3), p.e107405-n/a [Peer Reviewed Journal]

2021 The Authors ;2021 EMBO ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2020107405 ;PMID: 33522642

Full text available

3
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
Material Type:
Article
Add to My Research

Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases

Annals of the rheumatic diseases, 2022-05, Vol.81 (5), p.720-728 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-221508 ;PMID: 35022159

Full text available

4
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
Material Type:
Article
Add to My Research

Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells

Journal of virology, 2022-07, Vol.96 (14), p.e0060822-e0060822 [Peer Reviewed Journal]

Copyright © 2022 American Society for Microbiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.00608-22 ;PMID: 35862713

Full text available

5
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Material Type:
Article
Add to My Research

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Proceedings of the National Academy of Sciences - PNAS, 2022-05, Vol.119 (20), p.e2120976119-e2120976119 [Peer Reviewed Journal]

Copyright National Academy of Sciences May 17, 2022 ;Attribution ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120976119 ;PMID: 35549549

Full text available

6
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
Material Type:
Article
Add to My Research

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Blood, 2022-02, Vol.139 (6), p.942-946 [Peer Reviewed Journal]

2022 American Society of Hematology ;Copyright ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013714 ;PMID: 34905598

Full text available

7
Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth
Material Type:
Article
Add to My Research

Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth

Proceedings of the National Academy of Sciences - PNAS, 2021-11, Vol.118 (48) [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Nov 30, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2105927118 ;PMID: 34819367

Full text available

8
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Material Type:
Article
Add to My Research

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

Journal of virology, 2024-01 [Peer Reviewed Journal]

Copyright ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.01351-23 ;PMID: 38088562

Digital Resources/Online E-Resources

9
Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol
Material Type:
Article
Add to My Research

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol

BMJ open, 2019-04, Vol.9 (4), p.e028444-e028444 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-028444 ;PMID: 31005944

Full text available

10
Abstract PR04: Potential of metformin to modify the gut microbiota and prevent inflammation in nondiabetic people with HIV
Material Type:
Article
Add to My Research

Abstract PR04: Potential of metformin to modify the gut microbiota and prevent inflammation in nondiabetic people with HIV

Cancer research (Chicago, Ill.), 2020-04, Vol.80 (8_Supplement), p.PR04-PR04 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.MVC2020-PR04

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait